NIH to Grant Exclusive License for Autoimmune Disease and Transplant Rejection Treatments

Summary

The National Institutes of Health is issuing a notice to grant a worldwide, limited field of use, exclusive license to Sentron Medical, Inc. for the inventions related to treating autoimmune diseases and transplant rejection, as assigned by the US government.